Bio Rad Laboratories Inc reports results for the quarter ended in September - Earnings Summary

Bio-Rad Laboratories

26/10/2023 23:21

* Bio Rad Laboratories Inc  BIO.N  reported quarterly
adjusted
earnings of $2.33​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for earnings of $2.78 per share.
    * Revenue fell 7.2% to $632.10 million from a year ago;
analysts
expected $689.57 million. 
    * Bio Rad Laboratories Inc's reported EPS for the quarter
was
$3.64​.
    * The mean earnings estimate of analysts had fallen by
about 15.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Bio Rad Laboratories Inc shares had fallen by 19.1% this
quarter and lost 31.0% so far this year.
    * The company reported quarterly net income of $106.26
million.
    * Wall Street's median 12-month price target for Bio Rad
Laboratories Inc is $525.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 26 at 10:20 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      2.78           2.33           Missed
 Jun. 30 2023      2.68           3.00           Beat
 Mar. 31 2023      3.54           3.34           Missed
 Dec. 31 2022      3.45           3.31           Missed